ANI converts all Series A preferred to common; 602,900 shares issued, preferred eliminated

ANI PHARMACEUTICALS INC

On Sep 26, 2025, ANI mandatorily converted 20,000 preferred shares into 482,320 common shares at $41.4662/share.
On Aug 14, 2025, Ampersand converted 5,000 preferred shares into 120,580 common shares at the same price.
All 25,000 preferred shares converted into 602,900 common shares; no preferred shares remain outstanding.
Mandatory conversion triggered because 20-day VWAP exceeded 170% of conversion price ($70.50) after second anniversary.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.